EA202092869A1 - METHODS AND COMPOSITIONS INCLUDING BUCINDOLOL FOR ATRIAL FIBRILLATION TREATMENT - Google Patents

METHODS AND COMPOSITIONS INCLUDING BUCINDOLOL FOR ATRIAL FIBRILLATION TREATMENT

Info

Publication number
EA202092869A1
EA202092869A1 EA202092869A EA202092869A EA202092869A1 EA 202092869 A1 EA202092869 A1 EA 202092869A1 EA 202092869 A EA202092869 A EA 202092869A EA 202092869 A EA202092869 A EA 202092869A EA 202092869 A1 EA202092869 A1 EA 202092869A1
Authority
EA
Eurasian Patent Office
Prior art keywords
bucindolol
methods
atrial fibrillation
compositions including
fibrillation treatment
Prior art date
Application number
EA202092869A
Other languages
Russian (ru)
Inventor
Майкл Бристоу
Кристофер Дафтон
Original Assignee
Арка Байофарма Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Арка Байофарма Инк. filed Critical Арка Байофарма Инк.
Priority claimed from PCT/US2019/034019 external-priority patent/WO2019227056A2/en
Publication of EA202092869A1 publication Critical patent/EA202092869A1/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Способы и композиции по настоящему изобретению относятся к лечению фибрилляции предсердий буциндололом у пациентов, включая пациентов с сердечной недостаточностью, после определения того, что они являются гомозиготными по Arg389 в гене 1-адренергического рецептора.The methods and compositions of the present invention relate to the treatment of atrial fibrillation with bucindolol in patients, including patients with heart failure, after determining that they are homozygous for Arg389 in the 1-adrenergic receptor gene.

EA202092869A 2019-04-26 2019-05-24 METHODS AND COMPOSITIONS INCLUDING BUCINDOLOL FOR ATRIAL FIBRILLATION TREATMENT EA202092869A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962839531P 2019-04-26 2019-04-26
PCT/US2019/034019 WO2019227056A2 (en) 2018-05-25 2019-05-24 Methods and compositions involving bucindolol for the treatment of atrial fibrillation

Publications (1)

Publication Number Publication Date
EA202092869A1 true EA202092869A1 (en) 2021-10-06

Family

ID=78572582

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202092869A EA202092869A1 (en) 2019-04-26 2019-05-24 METHODS AND COMPOSITIONS INCLUDING BUCINDOLOL FOR ATRIAL FIBRILLATION TREATMENT

Country Status (1)

Country Link
EA (1) EA202092869A1 (en)

Similar Documents

Publication Publication Date Title
AU2018236800B2 (en) DNA-PK inhibitors
EA201990019A1 (en) COMPOUNDS AND COMPOSITIONS FOR SUSPENSION OF SHP2 ACTIVITY
EA202091709A1 (en) DNA PC INHIBITORS
EP4257152A3 (en) Apelin polypeptides
EA201692177A1 (en) CONNECTIONS AND COMPOSITIONS AS AN AGONISTS OF TOLL-LIKE RECEPTOR 7
EA201290894A1 (en) AZETIDINE DERIVATIVES OF PIPERIDIN-4-ILA AS JAK1 INHIBITORS
BR112016017564A8 (en) methods and compositions for killing senescent cells and for treating senescence-associated diseases and disorders
EP4234017A3 (en) 4-methylsulfonyl-substituted piperidine urea compounds useful for the treatment of cardiac disorders such as dilated cardiomyopathy (dcm)
EA201892075A1 (en) COMBINATION OF LSD1 INHIBITORS FOR USE FOR THE TREATMENT OF SOLID TUMORS
MX2017015521A (en) Substituted heterocyclyl derivatives as cdk inhibitors.
BR112017009671A2 (en) ezh2 inhibitors and uses of these
EA201891143A1 (en) PIPERIDINON AGONISTS OF FORMILPEPTID RECEPTOR 2 AND FORMILPEPTID RECEPTOR 1
EA201891913A1 (en) IMPROVED PREPARATIONS OF ADOLESCENT CELLS OF ADULT LIVER
BR112018071602A2 (en) substituted imidazopyridine compounds as inhibitors of indolamine 2,3-dioxigenase and / or tryptophan-2,3-dioxigenase
EA202091708A1 (en) DNA PC INHIBITORS
EA201791021A1 (en) 1- [2- (AMINOMETHYL) BENZYL] -2-THIOXO-1,2,3,5-TETRAHYDRO-4H-PYRROLO [3,2-d] PYRIMIDIN-4-ONE AS INHIBITORS MYELOPEROXIDASE
EA201692474A1 (en) DERIVATIVES 1- (CYCLOPENT-2-EN-1-IL) -3- (2-HYDROXY-3- (ARYLSULFONIL) PHENYL) URECHEN AS CXCR2 Inhibitors
EA201891710A1 (en) THERAPEUTIC CONNECTIONS
EA202091655A1 (en) COMPOSITIONS AND METHODS FOR TREATMENT OF RETINAL DISORDERS
EA202092695A1 (en) COMPOSITIONS CONTAINING GLUCOSE AND HEMICELLULOSE AND THEIR APPLICATION
EA202092748A1 (en) APOL1 EXPRESSION MODULATORS
EA201692518A2 (en) METHODS TO IMPROVE MYOCARDIAL PERFORMANCE IN PATIENTS AFTER FONTENE OPERATION USING UDENAFIL COMPOSITIONS
BR112018068960A2 (en) enalapril formulations
BR112017001971A2 (en) Methods and compositions for diagnosing and treating inflammatory bowel disorders
EA202092869A1 (en) METHODS AND COMPOSITIONS INCLUDING BUCINDOLOL FOR ATRIAL FIBRILLATION TREATMENT